Prevalence of resistance-associated substitutions and retreatment of patients failing a glecaprevir/pibrentasvir regimen
Adolfo de Salazar(Instituto de Investigación Biosanitaria de Granada), Eiko Schnaitmann, Joaquín Cabezas(Instituto de Investigación Marqués de Valdecilla), B. Görlitz, Massimo Puoti(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), R Schöfl(Ordensklinikum Linz Barmherzige Schwestern), Stefania Paolucci(Policlinico San Matteo Fondazione), Rudolf Stauber(Medical University of Graz), Julia Dietz(National Institute for Health and Care Excellence), M. Aragri(University of Rome Tor Vergata), Féderico García, Miguel García Deltoro(Hospital General Universitario De Valencia), Beat Müllhaupt(University Hospital of Zurich), Lars Reinhardt, Volker Ellenrieder, Johanna Backhus(Universität Ulm), Juan Manuel Pascasio Acevedo(Hospital Universitario Virgen del Rocío), Thomas Seufferlein(Universität Ulm), M. Dreck(University of Rome Tor Vergata), Nicola Coppola(University of Campania "Luigi Vanvitelli"), Velia Chiara Di Maio(University of Rome Tor Vergata), Francesca Ceccherini‐Silberstein(University of Cologne), Christoph Sarrazin(St. Josefs Hospital), Johannes Vermehren, Valeria Micheli(ASST Fatebenefratelli Sacco), Tobias Götze, Holger Hinrichsen(Kiel University), Francisco Téllez(Hospital Universitario Puerto Real), José Miguel Rosales Zábal(Hospital Costa del Sol), Michael Manns(Medizinische Hochschule Hannover), Barbara Seegers(Clinical Research Center Kiel), Juan Ignacio Arenas Ruiz Tapiador(Biogipuzkoa Health Research Institute), Christiana Graf(Goethe University Frankfurt), Eugen Zizer(Universität Ulm), Susanne Beckebaum(Essen University Hospital), S Hametner, Kerstin Port(Medizinische Hochschule Hannover), Miguel A. Jiménez(Hospital Regional Universitario de Málaga), Manuel Alberto Macías Rodríguez(Hospital Universitario Puerta del Mar), Annapaola Callegaro(Ospedale Papa Giovanni XXIII), V. Meister, R. Link, Ali Canbay(Universitätsklinikum Knappschaftskrankenhaus Bochum), M. Jung, Markus Cornberg(Medizinische Hochschule Hannover)
Cited by 22
Related Papers
Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2015|1.3k
Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial
|The Lancet|2018|1.3k
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2019|1.2k
Connections between single-cell biomechanics and human disease states: gastrointestinal cancer and malaria
|Acta Biomaterialia|2004|870
Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
|The Lancet. Gastroenterology & hepatology|2022|664